share_log

Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

SEC ·  Aug 11, 2022 06:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more